Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson's disease related dementia.

作者: J.L.W. Bosboom , D. Stoffers , C.J. Stam , H.W. Berendse , E.Ch. Wolters

DOI: 10.1016/J.CLINPH.2009.03.004

关键词:

摘要: Abstract Objective EEG and MEG studies in Parkinson’s disease (PD) related dementia (PDD) have shown a slowing of resting-state, oscillatory activity compared to non demented PD. Aim the present study was determine whether treatment with cholinesterase inhibitor rivastigmine would reverse this resting-state PDD patients. Methods In eight patients, whole head recorded condition before after rivastigmine. Relative spectral power calculated delta, theta, alpha, beta gamma frequency bands fronto-central, parieto-occipital temporal regions. Results After rivastigmine, patients demonstrated an increase relative alpha range regions together diffuse power. Furthermore, decrease delta fronto-central found. Conclusions Treatment at least partly counteracts brain that is known occur PD dementia. Significance Our observations emphasize prominent role degeneration cholinergic system pathophysiology future, might contribute selection who may optimally benefit from treatment.

参考文章(51)
S Fahn, Unified Parkinson's Disease Rating Scale Recent developments in Parkinson's disease. ,vol. 2, pp. 293- 304 ,(1987)
M Goldstein, DB Calne, RL Elton, CD Marsden, S Fahn, Recent Developments in Parkinson's Disease ,(1986)
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh, “Mini-mental state” Journal of Psychiatric Research. ,vol. 12, pp. 189- 198 ,(1975) , 10.1016/0022-3956(75)90026-6
Jacqueline S Birks, Cholinesterase inhibitors for Alzheimer's disease Cochrane Database of Systematic Reviews. ,(2006) , 10.1002/14651858.CD005593
S Brassen, K Chwalek, M Teufel, B Dieter, G Adler, Prediction of treatment response to rivastigmine in Alzheimer’s dementia Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 75, pp. 292- 294 ,(2004) , 10.1136/JNNP.2003.012518
W. R. Gibb, Accuracy in the clinical diagnosis of parkinsonian syndromes. Postgraduate Medical Journal. ,vol. 64, pp. 345- 351 ,(1988) , 10.1136/PGMJ.64.751.345
Paavo Riekkinen, Jouni Sirvio¨, Minna Riekkinen, Paavo Riekkinen, EEG changes induced by acute and chronic quisqualic or ibotenic acid nucleus basalis lesions are stabilized by tacridine. Brain Research. ,vol. 559, pp. 304- 308 ,(1991) , 10.1016/0006-8993(91)90016-O
Hans C Dringenberg, Peter Diavolitsis, Peter A Noseworthy, Effect of tacrine on EEG slowing in the rat: enhancement by concurrent monoamine therapy. Neurobiology of Aging. ,vol. 21, pp. 135- 143 ,(2000) , 10.1016/S0197-4580(00)00108-1
Ebert, Kirch, Scopolamine model of dementia: electroencephalogram findings and cognitive performance European Journal of Clinical Investigation. ,vol. 28, pp. 944- 949 ,(1998) , 10.1046/J.1365-2362.1998.00393.X
T. C. Buter, A. van den Hout, F. E. Matthews, J. P. Larsen, C. Brayne, D. Aarsland, Dementia and survival in Parkinson disease: A 12-year population study Neurology. ,vol. 70, pp. 1017- 1022 ,(2008) , 10.1212/01.WNL.0000306632.43729.24